In view of this, we postulate that the PACAP may attenuate brain edema by inhibiting thrombin- and platelet aggregation-induced impairment of CSF circulation after hemorrhagic stroke, which is worthy of further investigation in the future. Here, ADCYAP1 is linked to hemorrhagic stroke.